SUBSCRIBE
SUBSCRIBE
News   Deals

Ipsen Aims To Raise €400 Million In IPO

November 23, 2005 | 
1 min read
Ipsen, the French pharmaceuticals company, yesterday unveiled plans to raise about €400m ($470m) in an initial public offering, which would reduce the stake of the family of founder Henri Beaufour and raise funds for research.
IPO Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
Business people shaking hand in China.
GLP-1
Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal
February 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Contemporary art collage. Purple hand holding fan of dollar bills against bright yellow background. stock photo
Collaboration
Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer
February 24, 2026
 · 
2 min read
 · 
Tristan Manalac
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
 · 
5 min read
 · 
Tristan Manalac
Hand collage holding dollar paper money isolated on yellow background. Using cash to buy concept. Halftone effect in pop art style illustration.
Mergers & acquisitions
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition
February 23, 2026
 · 
2 min read
 · 
Tristan Manalac